Leonteq Securities AG’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10
Closed -$112 1258
2024
Q3
$112 Sell
10
-857
-99% -$9.11K ﹤0.01% 1175
2024
Q2
$8.67K Hold
867
﹤0.01% 997
2024
Q1
$9.98K Hold
867
﹤0.01% 1011
2023
Q4
$6.32K Buy
867
+515
+146% +$4.06K ﹤0.01% 1030
2023
Q3
$3.2K Hold
352
﹤0.01% 1109
2023
Q2
$4.28K Sell
352
-469
-57% -$5.23K ﹤0.01% 1120
2023
Q1
$10.2K Buy
821
+675
+462% +$12.4K ﹤0.01% 1019
2022
Q4
$2.81K Hold
146
﹤0.01% 1180
2022
Q3
$2.74K Sell
146
-3,304
-96% -$67.9K ﹤0.01% 1171
2022
Q2
$62.2K Buy
3,450
+150
+5% +$2.44K ﹤0.01% 780
2022
Q1
$52.9K Hold
3,300
﹤0.01% 851
2021
Q4
$80.7K Hold
3,300
﹤0.01% 814
2021
Q3
$76.9K Buy
+3,300
New +$79.8K ﹤0.01% 773

Other funds holding AHCO

Leonteq Securities AG's AHCO Position: Q4 2024 in Review

Leonteq Securities AG sold out of AdaptHealth (AHCO) in Q4 2024, closing a stake of 10 shares — an estimated $112 sold.

Leonteq Securities AG first reported a position in AHCO in Q3 2021 and held it in 13 quarters. The position peaked at $80.7K in Q4 2021. 200 funds tracked by Wall St. Rank hold AHCO as of Q4 2024.

  • Leonteq Securities AG reported no remaining AdaptHealth position as of Q4 2024 after selling out during the quarter.
  • Leonteq Securities AG sold 10 AdaptHealth shares in Q4 2024, an estimated $112.
  • Leonteq Securities AG first reported a position in AdaptHealth in Q3 2021 and held it in 13 quarters.
  • Leonteq Securities AG's AdaptHealth position peaked at $80.7K in Q4 2021.
  • 200 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2024.

Based on Leonteq Securities AG's 13F filing for Q4 2024, filed 23 Feb 2026.